Pediatric hearing loss
1Division of Otolaryngology, University of Connecticut School of Medicine, and Division of Otolaryngology-Head and Neck Surgery, Connecticut Children's Medical Center, Hartford, CT.
Insights
Universal newborn screening is recommended before 1 month, with follow-up testing by 3 months and intervention by 6 months for infants. Early hearing tests and tympanostomy tubes for persistent middle ear issues are crucial for children.
Area of Science:
- Pediatrics
- Audiology
- Genetics
Background:
- Congenital hearing loss is a common birth defect.
- Genetic factors are the most frequent cause of congenital hearing loss, often nonsyndromic.
- Early detection and intervention are critical for developmental outcomes.
Purpose of the Study:
- To outline evidence-based guidelines for newborn hearing screening.
- To provide recommendations for managing persistent middle ear effusion and hearing loss in children.
- To emphasize the genetic basis of congenital hearing loss.
Main Methods:
- Review of strong research findings.
- Consideration of consensus statements in pediatric audiology and genetics.
- Analysis of data on screening timelines and intervention timing.
Main Results:
- Universal newborn screening recommended before 1 month, with repeat testing by 3 months and intervention by 6 months.
- Tympanostomy tubes suggested for persistent middle ear effusion (≥3 months) with conductive hearing loss.
- Age-appropriate hearing tests are advised for all children with suspected hearing loss.
- Genetic factors are the primary cause of congenital hearing loss, predominantly nonsyndromic.
Conclusions:
- Timely newborn screening and intervention significantly impact outcomes for congenital hearing loss.
- Management of persistent middle ear effusion requires prompt audiological assessment and consideration of tympanostomy tubes.
- Understanding the genetic etiology of hearing loss is essential for comprehensive care.
Abstract:
On the basis of strong research, universal newborn screening should be performed before age 1 month with repeat or follow-up testing for those who do not pass performed before age 3 months and intervention started before age 6 months. On the basis of strong research and consensus statement, tympanostomy tubes should be considered for individuals with bilateral persistent middle ear effusion for 3 months or greater and a documented conductive hearing loss. On the basis of consensus statement, all children with suspected hearing loss should have an age appropriate hearing test. On the basis of strong research, the most common form of congenital hearing loss is genetic. Most of this is nonsyndromic hearing loss.
More Related Videos
06:04Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
06:27Simple Surgical Induction of Conductive Hearing Loss with Verification Using Otoscope Visualization and Behavioral Clap Startle Response in Rat
Published on: October 26, 2019
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Hearing
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
